Clovis Oncology, Inc.

JPMORGAN CHASE & CO

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

10,183

Value ($000)

12

Weight

0.0%

2013 Q4 - 2022 Q3 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	12	0.0%	10,183	9/30/2022
2022 Q2	8/11/2022	10	0.0%	5,640	6/30/2022
2022 Q1	5/11/2022	141	0.0%	69,772	3/31/2022
2021 Q4	2/11/2022	153	0.0%	56,359	12/31/2021
2021 Q3	11/12/2021	229	0.0%	51,446	9/30/2021
2021 Q2	8/12/2021	257	0.0%	44,255	6/30/2021
2021 Q1	5/12/2021	1,221	0.0%	173,891	3/31/2021
2020 Q4	2/19/2021	1,041	0.0%	217,137	12/31/2020
2020 Q3	11/12/2020	1,482	0.0%	249,536	9/30/2020
2020 Q2	8/11/2020	1,811	0.0%	268,177	6/30/2020
2020 Q1	5/12/2020	2,117	0.0%	332,971	3/31/2020
2019 Q4	2/11/2020	4,443	0.0%	426,043	12/31/2019
2014 Q1	5/15/2014	7,532	0.0%	108,739	3/31/2014
2013 Q4	2/26/2014	4,101	0.0%	68,026	12/31/2013